The Manufacturers Life Insurance Company Purchases New Holdings in Addus HomeCare Corporation $ADUS

The Manufacturers Life Insurance Company acquired a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUSFree Report) during the 2nd quarter, Holdings Channel.com reports. The fund acquired 8,963 shares of the company’s stock, valued at approximately $901,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of ADUS. Global Retirement Partners LLC increased its stake in shares of Addus HomeCare by 395.7% during the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after purchasing an additional 186 shares in the last quarter. Larson Financial Group LLC boosted its position in shares of Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares in the last quarter. NFJ Investment Group LLC purchased a new stake in shares of Addus HomeCare in the 2nd quarter worth approximately $29,000. Acumen Wealth Advisors LLC purchased a new stake in shares of Addus HomeCare in the 4th quarter worth approximately $29,000. Finally, Arax Advisory Partners increased its position in Addus HomeCare by 95.8% during the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after buying an additional 137 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on ADUS shares. Barclays lifted their price objective on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research note on Wednesday, July 8th. Royal Bank Of Canada raised their price target on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Weiss Ratings raised Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Citigroup reiterated a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Finally, Citizens Jmp reissued a “market outperform” rating and set a $142.00 price objective on shares of Addus HomeCare in a research report on Monday, May 18th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $128.86.

Get Our Latest Stock Analysis on ADUS

Addus HomeCare Stock Up 0.1%

ADUS stock opened at $118.76 on Friday. Addus HomeCare Corporation has a 1-year low of $87.95 and a 1-year high of $124.43. The business has a fifty day moving average price of $114.01 and a 200-day moving average price of $103.20. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69. The stock has a market capitalization of $2.22 billion, a P/E ratio of 20.84, a P/E/G ratio of 1.59 and a beta of 0.86.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its quarterly earnings data on Monday, August 3rd. The company reported $1.73 EPS for the quarter, beating the consensus estimate of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The company had revenue of $377.41 million for the quarter, compared to analysts’ expectations of $376.24 million. During the same period last year, the firm posted $1.49 earnings per share. Addus HomeCare’s revenue was up 8.0% compared to the same quarter last year. Equities analysts forecast that Addus HomeCare Corporation will post 6.3 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider Heather Dixon sold 288 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total value of $27,005.76. Following the transaction, the insider owned 44,371 shares of the company’s stock, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 4.10% of the company’s stock.

About Addus HomeCare

(Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Read More

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.